{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,9]],"date-time":"2026-02-09T20:33:49Z","timestamp":1770669229033,"version":"3.49.0"},"reference-count":77,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2020,3,13]],"date-time":"2020-03-13T00:00:00Z","timestamp":1584057600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,3,13]],"date-time":"2020-03-13T00:00:00Z","timestamp":1584057600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Drug Deliv. and Transl. Res."],"published-print":{"date-parts":[[2020,8]]},"DOI":"10.1007\/s13346-020-00741-4","type":"journal-article","created":{"date-parts":[[2020,3,13]],"date-time":"2020-03-13T18:02:47Z","timestamp":1584122567000},"page":"962-974","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":22,"title":["Vaginal siRNA delivery: overview on novel delivery approaches"],"prefix":"10.1007","volume":"10","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2842-2486","authenticated-orcid":false,"given":"Krishna","family":"Baxi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0473-4979","authenticated-orcid":false,"given":"Sujata","family":"Sawarkar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5908-2627","authenticated-orcid":false,"given":"Munira","family":"Momin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6661-3238","authenticated-orcid":false,"given":"Vainav","family":"Patel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3831-4366","authenticated-orcid":false,"given":"Trinette","family":"Fernandes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,3,13]]},"reference":[{"key":"741_CR1","unstructured":"World Health Organisation. HIV\/AIDS. https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/hiv-aids. Accessed 7 Feb 2019; 2018."},{"key":"741_CR2","unstructured":"amfAR: Statistics: Worldwide. The Foundation for AIDS Research HIV \/ AIDS Research. https:\/\/www.amfar.org\/worldwide-aids-stats\/. Accessed 7 Feb 2019; 2018."},{"key":"741_CR3","unstructured":"UNAIDS Global HIV & AIDS statistics \u2014 2018 fact sheet | UNAIDS. http:\/\/www.unaids.org\/en\/resources\/fact-sheet. Accessed 7 Feb 2019."},{"key":"741_CR4","unstructured":"HIV Facts & Figures | National AIDS Control Organization | MoHFW | GoI. http:\/\/naco.gov.in\/hiv-facts-figures. Accessed 7 Feb 2019; 2018."},{"key":"741_CR5","unstructured":"World Health Organization: Factsheets: Herpes Simplex Virus. https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/herpes-simplex-virus; 2017."},{"key":"741_CR6","unstructured":"World Health Organization: Sexually transmitted infections (STIs). https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/sexually-transmitted-infections-(stis); 2016."},{"key":"741_CR7","unstructured":"The HIV life cycle | Understanding HIV\/AIDS | AIDSinfo. https:\/\/aidsinfo.nih.gov\/understanding-hiv-aids\/fact-sheets\/19\/73\/the-hiv-life-cycle. Accessed 7 Feb 2019; 2018."},{"key":"741_CR8","volume-title":"Pathogenesis and disease","author":"R Whitley","year":"2007","unstructured":"Whitley R, Kimberlin DW, Prober CG. Pathogenesis and disease. Cambridge: Cambridge University Press; 2007."},{"key":"741_CR9","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1038\/nrc798","volume":"2","author":"H zur Hausen","year":"2002","unstructured":"zur Hausen H. Papillomaviruses and cancer: from basic studies to clinical application. Nat Rev Cancer. 2002;2:342\u201350.","journal-title":"Nat Rev Cancer"},{"key":"741_CR10","volume-title":"Microbicides","year":"2006","unstructured":"WHO. Microbicides. Geneva: WHO; 2006."},{"key":"741_CR11","doi-asserted-by":"publisher","unstructured":"Wilkinson D, Ramjee G, Tholandi M, Rutherford GW. Nonoxynol-9 for preventing vaginal acquisition of sexually transmitted infections by women from men. Cochrane Database Syst Rev. 2002. https:\/\/doi.org\/10.1002\/14651858.CD003939.","DOI":"10.1002\/14651858.CD003939"},{"key":"741_CR12","doi-asserted-by":"crossref","first-page":"e1312","DOI":"10.1371\/journal.pone.0001312","volume":"2","author":"L Peterson","year":"2007","unstructured":"Peterson L, Nanda K, Opoku BK, et al. SAVVY\u00ae (C31G) gel for prevention of HIV infection in women: a phase 3, double-blind, randomized, placebo-controlled trial in Ghana. PLoS One. 2007;2:e1312.","journal-title":"PLoS One"},{"key":"741_CR13","volume-title":"Cellulose sulfate microbicide trial stopped","year":"2010","unstructured":"WHO. Cellulose sulfate microbicide trial stopped. Geneva: WHO; 2010."},{"key":"741_CR14","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.3851\/IMP1890","volume":"16","author":"D Marais","year":"2011","unstructured":"Marais D, Gawarecki D, Allan B, Ahmed K, Altini L, Cassim N, et al. The effectiveness of Carraguard, a vaginal microbicide, in protecting women against high-risk human papillomavirus infection. Antivir Ther. 2011;16:1219\u201326.","journal-title":"Antivir Ther"},{"key":"741_CR15","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1016\/S0140-6736(10)61086-0","volume":"376","author":"S McCormack","year":"2010","unstructured":"McCormack S, Ramjee G, Kamali A, et al. PRO2000 vaginal gel for prevention of HIV-1 infection (Microbicides Development Programme 301): a phase 3, randomised, double-blind, parallel-group trial. Lancet. 2010;376:1329\u201337.","journal-title":"Lancet"},{"key":"741_CR16","unstructured":"Microbicides Development Programme. http:\/\/www.mdp.mrc.ac.uk\/; 2012."},{"key":"741_CR17","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.antiviral.2012.08.004","volume":"96","author":"CS Dezzutti","year":"2012","unstructured":"Dezzutti CS, Shetler C, Mahalingam A, Ugaonkar SR, Gwozdz G, Buckheit KW, et al. Safety and efficacy of tenofovir\/IQP-0528 combination gels \u2013 a dual compartment microbicide for HIV-1 prevention. Antivir Res. 2012;96:221\u20135.","journal-title":"Antivir Res"},{"key":"741_CR18","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1038\/nri1848","volume":"6","author":"MM Lederman","year":"2006","unstructured":"Lederman MM, Offord RE, Hartley O. Microbicides and other topical strategies to prevent vaginal transmission of HIV. Nat Rev Immunol. 2006;6:371\u201382.","journal-title":"Nat Rev Immunol"},{"key":"741_CR19","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1038\/35888","volume":"391","author":"A Fire","year":"1998","unstructured":"Fire A, SiQun X, Mary M, Steven K, Samuel D, Craig M. Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans. Nature. 1998;391:806\u201311.","journal-title":"Nature"},{"key":"741_CR20","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1016\/j.cell.2005.10.022","volume":"123","author":"RI Gregory","year":"2005","unstructured":"Gregory RI, Chendrimada TP, Cooch N, Shiekhattar R. Human RISC couples microRNA biogenesis and posttranscriptional gene silencing. Cell. 2005;123:631\u201340.","journal-title":"Cell"},{"key":"741_CR21","first-page":"187","volume":"85","author":"K Gavrilov","year":"2012","unstructured":"Gavrilov K, Saltzman WM. Therapeutic siRna : principles , challenges. Yale J Biol Med. 2012;85:187\u2013200.","journal-title":"Yale J Biol Med"},{"key":"741_CR22","doi-asserted-by":"crossref","first-page":"38e","DOI":"10.1093\/nar\/gng038","volume":"31","author":"M Sohail","year":"2003","unstructured":"Sohail M. A simple and cost-effective method for producing small interfering RNAs with high efficacy. Nucleic Acids Res. 2003;31:38e\u201338.","journal-title":"Nucleic Acids Res"},{"key":"741_CR23","doi-asserted-by":"crossref","first-page":"6047","DOI":"10.1073\/pnas.092143499","volume":"99","author":"J-Y Yu","year":"2002","unstructured":"Yu J-Y, DeRuiter SL, Turner DL. RNA interference by expression of short-interfering RNAs and hairpin RNAs in mammalian cells. Proc Natl Acad Sci. 2002;99:6047\u201352.","journal-title":"Proc Natl Acad Sci"},{"key":"741_CR24","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1073\/pnas.2136685100","volume":"101","author":"L Zheng","year":"2004","unstructured":"Zheng L, Liu J, Batalov S, Zhou D, Orth A, Ding S, et al. An approach to genomewide screens of expressed small interfering RNAs in mammalian cells. Proc Natl Acad Sci. 2004;101:135\u201340.","journal-title":"Proc Natl Acad Sci"},{"key":"741_CR25","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1080\/15384047.2016.1156266","volume":"17","author":"Y Diao","year":"2016","unstructured":"Diao Y, Liu J, Ma Y, Su M, Zhang H, Hao X. A specific aptamer-cell penetrating peptides complex delivered siRNA efficiently and suppressed prostate tumor growth in vivo. Cancer Biol Ther. 2016;17:498\u2013506.","journal-title":"Cancer Biol Ther"},{"key":"741_CR26","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/j.jconrel.2017.09.042","volume":"266","author":"C Gong","year":"2017","unstructured":"Gong C, Hu C, Gu F, Xia Q, Yao C, Zhang L, et al. Co-delivery of autophagy inhibitor ATG7 siRNA and docetaxel for breast cancer treatment. J Control Release. 2017;266:272\u201386.","journal-title":"J Control Release"},{"key":"741_CR27","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.ajo.2010.02.006","volume":"150","author":"PK Kaiser","year":"2010","unstructured":"Kaiser PK, Symons RCA, Shah SM, et al. RNAi-based treatment for neovascular age-related macular degeneration by Sirna-027. Am J Ophthalmol. 2010;150:33\u201339.e2.","journal-title":"Am J Ophthalmol"},{"key":"741_CR28","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.jconrel.2017.10.034","volume":"268","author":"H Nemati","year":"2017","unstructured":"Nemati H, Ghahramani M-H, Faridi-Majidi R, Izadi B, Bahrami G, Madani S-H, et al. Using siRNA-based spherical nucleic acid nanoparticle conjugates for gene regulation in psoriasis. J Control Release. 2017;268:259\u201368.","journal-title":"J Control Release"},{"key":"741_CR29","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.omtn.2017.08.013","volume":"9","author":"C Helmschrodt","year":"2017","unstructured":"Helmschrodt C, Hobel S, Schoniger S, Bauer A, Bonicelli J, Gringmuth M, et al. Polyethylenimine nanoparticle-mediated siRNA delivery to reduce a-synuclein expression in a model of Parkinson\u2019s disease. Mol Ther Nucleic Acids. 2017;9:57\u201368.","journal-title":"Mol Ther Nucleic Acids"},{"key":"741_CR30","unstructured":"Liberman J, Palliser D, Knipe, David inventor, president and fellows of Harvard College, Cambridge, MA, Immune Disease Institute I, Boston, Ma A (2012) siRNA Microbicides for preventing and treating diseases."},{"key":"741_CR31","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.addr.2008.09.008","volume":"61","author":"RA Cone","year":"2009","unstructured":"Cone RA. Barrier properties of mucus. Adv Drug Deliv Rev. 2009;61:75\u201385.","journal-title":"Adv Drug Deliv Rev"},{"key":"741_CR32","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1002\/wnan.144","volume":"3","author":"J das Neves","year":"2011","unstructured":"das Neves J, Amiji M, Sarmento B. Mucoadhesive nanosystems for vaginal microbicide development: friend or foe? Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2011;3:389\u201399.","journal-title":"Wiley Interdiscip Rev Nanomed Nanobiotechnol"},{"key":"741_CR33","doi-asserted-by":"crossref","first-page":"1482","DOI":"10.1073\/pnas.0608611104","volume":"104","author":"SK Lai","year":"2007","unstructured":"Lai SK, O\u2019Hanlon DE, Harrold S, Man ST, Wang YY, Cone R, et al. Rapid transport of large polymeric nanoparticles in fresh undiluted human mucus. PNAS. 2007;104:1482\u20137.","journal-title":"PNAS"},{"key":"741_CR34","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1016\/j.jconrel.2011.02.002","volume":"155","author":"SY Wu","year":"2011","unstructured":"Wu SY, Chang HI, Burgess M, McMillan NAJ. Vaginal delivery of siRNA using a novel PEGylated lipoplex-entrapped alginate scaffold system. J Control Release. 2011;155:418\u201326.","journal-title":"J Control Release"},{"key":"741_CR35","doi-asserted-by":"crossref","first-page":"1930","DOI":"10.1016\/S0006-3495(01)75844-4","volume":"81","author":"SS Olmsted","year":"2001","unstructured":"Olmsted SS, Padgett JL, Yudin AI, Whaley KJ, Moench TR, Cone RA. Diffusion of macromolecules and virus-like particles in human cervical mucus. Biophys J. 2001;81:1930\u20137.","journal-title":"Biophys J"},{"key":"741_CR36","first-page":"158","volume":"61","author":"SK Lai","year":"2010","unstructured":"Lai SK, Wang YY, Hanes J. NIH public access. Adv Drug Deliv Rev. 2010;61:158\u201371.","journal-title":"Adv Drug Deliv Rev"},{"key":"741_CR37","unstructured":"Sahoo CK, Nayak PK, Sarangi DK, Sahoo TK. Intra vaginal drug delivery system: an overview. Am J Adv Drug Deliv. 2013."},{"key":"741_CR38","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/0169-409X(92)90008-E","volume":"8","author":"JL Richardson","year":"1992","unstructured":"Richardson JL, Illum L. Routes of delivery: case studies. Adv Drug Deliv Rev. 1992;8:341\u201366.","journal-title":"Adv Drug Deliv Rev"},{"key":"741_CR39","first-page":"3","volume":"10","author":"N Dobaria","year":"2007","unstructured":"Dobaria N, Mashru R, Vadia NH. Novel vaginal drug delivery systems: a review. East Cent Afr J Pharm Sci. 2007;10:3\u201313.","journal-title":"East Cent Afr J Pharm Sci"},{"key":"741_CR40","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1097\/01.spv.0000094481.95144.3d","volume":"9","author":"SA Siddique","year":"2003","unstructured":"Siddique SA. Vaginal anatomy and physiology. J Pelvic Med Surg. 2003;9:263\u201372.","journal-title":"J Pelvic Med Surg"},{"key":"741_CR41","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1038\/nature07758","volume":"457","author":"D Castanotto","year":"2009","unstructured":"Castanotto D, Rossi JJ. The promises and pitfalls of RNA-interference-based therapeutics. Nature. 2009;457:426\u201333.","journal-title":"Nature"},{"key":"741_CR42","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1080\/10611860400006257","volume":"12","author":"IR Gilmore","year":"2004","unstructured":"Gilmore IR, Fox SP, Hollins AJ, Sohail M, Akhtar S. The design and exogenous delivery of siRNA for post-transcriptional gene silencing. J Drug Target. 2004;12:315\u201340.","journal-title":"J Drug Target"},{"key":"741_CR43","doi-asserted-by":"crossref","first-page":"147","DOI":"10.2174\/156720106776359159","volume":"3","author":"IR Gilmore","year":"2006","unstructured":"Gilmore IR, Fox SP, Hollins AJ, Akhtar S. Delivery strategies for siRNA-mediated gene silencing. Curr Drug Deliv. 2006;3:147\u201355.","journal-title":"Curr Drug Deliv"},{"key":"741_CR44","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1038\/nature04263","volume":"439","author":"D Palliser","year":"2006","unstructured":"Palliser D, Chowdhury D, Wang QY, Lee SJ, Bronson RT, Knipe DM, et al. An siRNA-based microbicide protects mice from lethal herpes simplex virus 2 infection. Nature. 2006;439:89\u201394.","journal-title":"Nature"},{"key":"741_CR45","doi-asserted-by":"crossref","first-page":"9726","DOI":"10.1002\/anie.200803526","volume":"47","author":"Y Wang","year":"2008","unstructured":"Wang Y, Lai SK, Pace A, Cone R. Addressing the PEG mucoadhesivity paradox to engineer nanoparticles that \u201cslip\u201d through the human mucus barrier. Angew Chem Int Ed Eng. 2008;47:9726\u20139.","journal-title":"Angew Chem Int Ed Eng"},{"key":"741_CR46","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/j.ijpharm.2015.02.041","volume":"483","author":"A Lechanteur","year":"2015","unstructured":"Lechanteur A, Furst T, Evrard B, Delvenne P, Hubert P, Piel G. Development of anti-E6 pegylated lipoplexes for mucosal application in the context of cervical preneoplastic lesions. Int J Pharm. 2015;483:268\u201377.","journal-title":"Int J Pharm"},{"key":"741_CR47","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/j.ejps.2016.08.058","volume":"93","author":"A Lechanteur","year":"2016","unstructured":"Lechanteur A, Furst T, Evrard B, Delvenne P, Hubert P, Piel G. PEGylation of lipoplexes: the right balance between cytotoxicity and siRNA effectiveness. Eur J Pharm Sci. 2016;93:493\u2013503.","journal-title":"Eur J Pharm Sci"},{"key":"741_CR48","doi-asserted-by":"crossref","first-page":"1706","DOI":"10.1021\/acs.molpharmaceut.6b01154","volume":"14","author":"A Lechanteur","year":"2017","unstructured":"Lechanteur A, Furst T, Evrard B, Delvenne P, Piel G, Hubert P. Promoting vaginal distribution of E7 and MCL-1 siRNA-silencing nanoparticles for cervical cancer treatment. Mol Pharm. 2017;14:1706\u201317.","journal-title":"Mol Pharm"},{"key":"741_CR49","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.jconrel.2016.06.028","volume":"236","author":"T Furst","year":"2016","unstructured":"Furst T, Dakwar GR, Zagato E, Lechanteur A, Remaut K, Evrard B, et al. Freeze-dried mucoadhesive polymeric system containing pegylated lipoplexes: towards a vaginal sustained released system for siRNA. J Control Release. 2016;236:68\u201378.","journal-title":"J Control Release"},{"key":"741_CR50","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.chom.2008.12.003","volume":"5","author":"Y Wu","year":"2009","unstructured":"Wu Y, Navarro F, Lal A, Basar E, Pandey RK, Feng Y, et al. Durable protection from herpes simplex Virus-2 transmission following intravaginal application of siRNAs targeting both a viral and host gene. Cell Host Microbe. 2009;5:84\u201394.","journal-title":"Cell Host Microbe"},{"key":"741_CR51","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1016\/j.ejpb.2008.09.024","volume":"71","author":"H de Martimprey","year":"2009","unstructured":"de Martimprey H, Vauthier C, Malvy C, Couvreur P. Polymer nanocarriers for the delivery of small fragments of nucleic acids: oligonucleotides and siRNA. Eur J Pharm Biopharm. 2009;71:490\u2013504.","journal-title":"Eur J Pharm Biopharm"},{"key":"741_CR52","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1007\/s13346-011-0048-9","volume":"2","author":"T Yu","year":"2012","unstructured":"Yu T, Wang YY, Yang M, et al. Biodegradable mucus-penetrating nanoparticles composed of diblock copolymers of polyethylene glycol and poly(lactic-co-glycolic acid). Drug Deliv Transl Res. 2012;2:124\u20138.","journal-title":"Drug Deliv Transl Res"},{"key":"741_CR53","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1038\/nmat2444","volume":"8","author":"KA Woodrow","year":"2009","unstructured":"Woodrow KA, Cu Y, Booth CJ, Saucier-sawyer JK, Monica J, Saltzman WM. Intravaginal gene silencing using biodegradable polymer nanoparticles densely loaded with small-interfering RNA. Nat Mater. 2009;8:526\u201333.","journal-title":"Nat Mater"},{"key":"741_CR54","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.ejpb.2010.11.008","volume":"77","author":"D Cun","year":"2011","unstructured":"Cun D, Jensen DK, Maltesen MJ, Bunker M, Whiteside P, Scurr D, et al. High loading efficiency and sustained release of siRNA encapsulated in PLGA nanoparticles: quality by design optimization and characterization. Eur J Pharm Biopharm. 2011;77:26\u201335.","journal-title":"Eur J Pharm Biopharm"},{"key":"741_CR55","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.jconrel.2012.06.008","volume":"162","author":"JM Steinbach","year":"2012","unstructured":"Steinbach JM, Weller CE, Booth CJ, Saltzman WM. Polymer nanoparticles encapsulating siRNA for treatment of HSV-2 genital infection. J Control Release. 2012;162:102\u201310.","journal-title":"J Control Release"},{"key":"741_CR56","doi-asserted-by":"crossref","first-page":"2889","DOI":"10.1021\/acs.molpharmaceut.5b00073","volume":"12","author":"J Gu","year":"2015","unstructured":"Gu J, Yang S, Ho EA. Biodegradable film for the targeted delivery of siRNA-loaded nanoparticles to vaginal immune cells. Mol Pharm. 2015;12:2889\u2013903.","journal-title":"Mol Pharm"},{"key":"741_CR57","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1002\/jgm.507","volume":"6","author":"A Kichler","year":"2004","unstructured":"Kichler A. Gene transfer with modified polyethylenimines. J Gene Med. 2004;6:3\u201310.","journal-title":"J Gene Med"},{"key":"741_CR58","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/S0169-409X(01)00202-2","volume":"53","author":"R Kircheis","year":"2001","unstructured":"Kircheis R, Wightman L, Wagner E. Design and gene delivery activity of modified polyethylenimines. Adv Drug Deliv Rev. 2001;53:341\u201358.","journal-title":"Adv Drug Deliv Rev"},{"key":"741_CR59","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1208\/s12248-010-9210-4","volume":"12","author":"J Wang","year":"2010","unstructured":"Wang J, Lu Z, Wientjes MG, Au JL-S. Delivery of siRNA therapeutics: barriers and carriers. AAPS J. 2010;12:492\u2013503.","journal-title":"AAPS J"},{"key":"741_CR60","doi-asserted-by":"crossref","first-page":"34","DOI":"10.2533\/chimia.1997.34","volume":"51","author":"JP Behr","year":"1997","unstructured":"Behr JP. The proton sponge. A trick to enter cells the viruses did not exploit. Chimia (Aarau). 1997;51:34\u20136.","journal-title":"Chimia (Aarau)"},{"key":"741_CR61","doi-asserted-by":"crossref","first-page":"7995","DOI":"10.3390\/ijms16047995","volume":"16","author":"SC Park","year":"2015","unstructured":"Park SC, Nam JP, Kim JH, Kim YM, Nah JW, Jang MK. Antimicrobial action of water-soluble \u03b2-chitosan against clinical multi-drug resistant bacteria. Int J Mol Sci. 2015;16:7995\u20138007.","journal-title":"Int J Mol Sci"},{"key":"741_CR62","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1016\/j.carres.2009.12.017","volume":"345","author":"M Artan","year":"2010","unstructured":"Artan M, Karadeniz F, Karagozlu MZ, Kim MM, Kim SK. Anti-HIV-1 activity of low molecular weight sulfated chitooligosaccharides. Carbohydr Res. 2010;345:656\u201362.","journal-title":"Carbohydr Res"},{"key":"741_CR63","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pone.0135288","volume":"10","author":"S Boyapalle","year":"2015","unstructured":"Boyapalle S, Xu W, Raulji P, Mohapatra S, Mohapatra SS. A multiple siRNA-based anti-HIV\/SHIV microbicide shows protection in both in vitro and in vivo models. PLoS One. 2015;10:1\u201316.","journal-title":"PLoS One"},{"key":"741_CR64","unstructured":"Hsu E, Fleet C, Cheung A, Gao J. High concentration chitosan-nucleic acid polyplex compositions. 2014:US8722646B2. https:\/\/patents.google.com\/patent\/US8722646B2\/en#patentCitations."},{"key":"741_CR65","first-page":"5383","volume":"10","author":"N Wu","year":"2015","unstructured":"Wu N, Zhang X, Li F, Zhang T, Gan Y, Li J. Spray-dried powders enhance vaginal siRNA delivery by potentially modulating the mucus molecular sieve structure. Int J Nanomedicine. 2015;10:5383\u201396.","journal-title":"Int J Nanomedicine"},{"key":"741_CR66","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/S0939-6411(00)00087-4","volume":"50","author":"R Muller","year":"2000","unstructured":"Muller R, Mader K, Gohla S. Solid lipid nanoparticles (SLN) for controlled drug delivery - a review of the state of the art. Eur J Pharm Biopharm. 2000;50:161\u201377.","journal-title":"Eur J Pharm Biopharm"},{"key":"741_CR67","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.ejpb.2016.10.017","volume":"109","author":"G B\u00fcy\u00fckk\u00f6ro\u011flu","year":"2016","unstructured":"B\u00fcy\u00fckk\u00f6ro\u011flu G, \u015eenel B, Ba\u015faran E, Yenilmez E, Yazan Y. Preparation and in vitro evaluation of vaginal formulations including siRNA and paclitaxel-loaded SLNs for cervical cancer. Eur J Pharm Biopharm. 2016;109:174\u201383.","journal-title":"Eur J Pharm Biopharm"},{"key":"741_CR68","doi-asserted-by":"crossref","first-page":"45","DOI":"10.3390\/biomedicines5030045","volume":"5","author":"S Kruspe","year":"2017","unstructured":"Kruspe S, Giangrande P. Aptamer-siRNA chimeras: discovery, progress, and future prospects. Biomedicines. 2017;5:45.","journal-title":"Biomedicines"},{"key":"741_CR69","doi-asserted-by":"crossref","first-page":"2401","DOI":"10.1172\/JCI45876","volume":"121","author":"LA Wheeler","year":"2011","unstructured":"Wheeler LA, Trifonova R, Vrbanac V, Basar E, McKernan S, Xu Z, et al. Inhibition of HIV transmission in human cervicovaginal explants and humanized mice using CD4 aptamer-siRNA chimeras. J Clin Invest. 2011;121:2401\u201312.","journal-title":"J Clin Invest"},{"key":"741_CR70","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/j.bbcan.2011.07.006","volume":"1816","author":"A Bolhassani","year":"2011","unstructured":"Bolhassani A. Potential efficacy of cell-penetrating peptides for nucleic acid and drug delivery in cancer. Biochim Biophys Acta Rev Cancer. 2011;1816:232\u201346.","journal-title":"Biochim Biophys Acta Rev Cancer"},{"key":"741_CR71","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1021\/bi0491604","volume":"44","author":"A Ziegler","year":"2005","unstructured":"Ziegler A, Nervi P, Durrenberger M, Seelig J. The cationic cell-penetrating peptide CPPTAT derived from the HIV-1 protein TAT is rapidly transported into living fibroblasts: optical, biophysical, and metabolic evidence. Biochemistry. 2005;44:138\u201348.","journal-title":"Biochemistry"},{"key":"741_CR72","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1038\/mt.2011.284","volume":"20","author":"H Margus","year":"2012","unstructured":"Margus H, Padari K, Pooga M. Cell-penetrating peptides as versatile vehicles for oligonucleotide delivery. Mol Ther. 2012;20:525\u201333.","journal-title":"Mol Ther"},{"key":"741_CR73","unstructured":"Bridge 2 Health The CIRM (ULg) develops innovative formulation for vaginal delivery of siRNA \u2013 Bridge2Health. https:\/\/b2h.be\/the-cirm-at-the-university-of-liege-develops-innovative-formulation-for-vaginal-delivery-of-sirna\/."},{"key":"741_CR74","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.actbio.2017.06.032","volume":"59","author":"Y Wan","year":"2017","unstructured":"Wan Y, Dai W, Nevagi RJ, Toth I, Moyle PM. Multifunctional peptide-lipid nanocomplexes for efficient targeted delivery of DNA and siRNA into breast cancer cells. Acta Biomater. 2017;59:257\u201368.","journal-title":"Acta Biomater"},{"key":"741_CR75","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.ijpharm.2016.10.009","volume":"515","author":"M Goldshtein","year":"2016","unstructured":"Goldshtein M, Forti E, Ruvinov E, Cohen S. Mechanisms of cellular uptake and endosomal escape of calcium-siRNA nanocomplexes. Int J Pharm. 2016;515:46\u201356.","journal-title":"Int J Pharm"},{"key":"741_CR76","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.jconrel.2010.02.003","volume":"144","author":"H Cao","year":"2010","unstructured":"Cao H, Jiang X, Chai C, Chew SY. RNA interference by nanofiber-based siRNA delivery system. J Control Release. 2010;144:203\u201312.","journal-title":"J Control Release"},{"key":"741_CR77","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.eurpolymj.2015.07.006","volume":"70","author":"F Brako","year":"2015","unstructured":"Brako F, Raimi-Abraham B, Mahalingam S, Craig DQM, Edirisinghe M. Making nanofibres of mucoadhesive polymer blends for vaginal therapies. Eur Polym J. 2015;70:186\u201396.","journal-title":"Eur Polym J"}],"container-title":["Drug Delivery and Translational Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13346-020-00741-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s13346-020-00741-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13346-020-00741-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,18]],"date-time":"2022-10-18T19:58:33Z","timestamp":1666123113000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s13346-020-00741-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3,13]]},"references-count":77,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2020,8]]}},"alternative-id":["741"],"URL":"https:\/\/doi.org\/10.1007\/s13346-020-00741-4","relation":{},"ISSN":["2190-393X","2190-3948"],"issn-type":[{"value":"2190-393X","type":"print"},{"value":"2190-3948","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,3,13]]},"assertion":[{"value":"13 March 2020","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}